Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema
Introduction. Diabetic retinopathy is the most common cause of visual loss and blindness in the age group of 20 to 64 years. This study aimed to evaluate the efficacy of oral Losartan adjuvant therapy in combination with intravitreal injection of Bevacizumab in the treatment of diabetic macular edem...
Main Authors: | Fariba Ghassemi, Abdulrahim Amini, Masoud Yasemi, Amin Nabavi, Mohammadkarim Johari |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/4528491 |
Similar Items
-
Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai
Published: (2012-01-01) -
Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai, et al.
Published: (2011-01-01) -
Intravitreal bevacizumab and diabetic papillopathy with macular edema
by: Beuy Joob, et al.
Published: (2012-01-01) -
Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01) -
Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema
by: Ahmed H Mohamed
Published: (2016-01-01)